GI
EWTX icon

GAMMA Investing’s Edgewise Therapeutics EWTX Stock Holding History

GAMMA Investing’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.6K Sell
2,107
-182
-8% -$6.27K ﹤0.01% 1924
2026
Q1 		$72.1K Buy
2,289
+935
+69% +$27K ﹤0.01% 1905
2025
Q4 		$33.6K Buy
1,354
+196
+17% +$3.93K ﹤0.01% 2318
2025
Q3 		$18.8K Sell
1,158
-8
-0.7% -$113 ﹤0.01% 2543
2025
Q2 		$15.3K Sell
1,166
-241
-17% -$3.48K ﹤0.01% 2597
2025
Q1 		$31K Buy
1,407
+86
+7% +$2.26K ﹤0.01% 2138
2024
Q4 		$35.3K Buy
1,321
+33
+3% +$1.05K ﹤0.01% 1932
2024
Q3 		$34.4K Buy
1,288
+101
+9% +$2.01K ﹤0.01% 1754
2024
Q2 		$21.4K Sell
1,187
-19
-2% -$331 ﹤0.01% 1812
2024
Q1 		$22K Buy
1,206
+100
+9% +$1.59K ﹤0.01% 1584
2023
Q4 		$19.7K Buy
+1,106
New +$7.76K 0.01% 1518

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GAMMA Investing's EWTX Position: Q2 2026 in Review

GAMMA Investing reduced its Edgewise Therapeutics (EWTX) stake by 8% in Q2 2026, selling an estimated $6.27K and leaving 2,107 shares worth $85.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

GAMMA Investing first reported a position in EWTX in Q4 2023 and has held it in 11 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • GAMMA Investing held 2,107 shares of Edgewise Therapeutics worth $85.6K as of Q2 2026.
  • GAMMA Investing sold 182 Edgewise Therapeutics shares in Q2 2026, an estimated $6.27K.
  • Edgewise Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1924 holding.
  • GAMMA Investing first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.